| Filed On | Filing |
|---|---|
| 13 Nov 2026 |
Form 4: Qiming Corporate Gp VI, Ltd., 10% owner and 6 others
Sold 100,117 shares ($2.94M) |
| 05 Nov 2026 |
Form 4: Qiming Corporate Gp VI, Ltd., 10% owner and 6 others
Sold 111,313 shares ($3.33M) |
| 04 Nov 2026 | 10-Q |
| 03 Nov 2026 |
Form 4: Qiming Corporate Gp VI, Ltd., 10% owner and 6 others
Sold 143,706 shares ($4.37M) · Sold 43,930 shares ($1.31M) |
| 03 Nov 2026 |
8-K: Results of Operations and Financial Condition; Departure/Election of Directors or Officers; Compensation
FREMONT, Calif. Nov. 03, 2026 (GLOBE NEWSWIRE) -- Alamar Biosciences, Inc. (Nasdaq: ALMR), a leader in precision proteomics dedicated to enabling the earliest detection of disease, today reported financial results for the quarter ended S... |
| 29 Oct 2026 |
Form 4: Qiming Corporate Gp VI, Ltd., 10% owner and 6 others
Sold 84,894 shares ($2.66M) · Sold 100,837 shares ($3.3M) |
| 27 Oct 2026 |
Form 4: Qiming Corporate Gp VI, Ltd., 10% owner and 6 others
Sold 147,934 shares ($4.53M) · Sold 132,524 shares ($4.04M) |
| 23 Oct 2026 |
Form 4: Qiming Corporate Gp VI, Ltd., 10% owner and 6 others
Sold 208,815 shares ($6.33M) · Sold 133,811 shares ($3.92M) |
| 21 Oct 2026 |
Form 4: Qiming Corporate Gp VI, Ltd., 10% owner and 6 others
Sold 75,508 shares ($1.99M) · Sold 142,004 shares ($3.96M) |
| 19 Oct 2026 |
Form 4: Qiming Corporate Gp VI, Ltd., 10% owner and 6 others
Sold 173,537 shares ($4.81M) · Sold 136 shares ($3.67K) |
| 14 Oct 2026 | 144 |
| 14 Oct 2026 | 144 |
| 14 Oct 2026 | 144 |
| 14 Oct 2026 | 144 |
| 16 Sep 2026 |
Form 4: Brottem John L., General Counsel
Received 29,000 shares as a grant or award · Granted 85,000 Employee Stock Option (right to buy) |
| 16 Sep 2026 |
Form 3: Brottem John L., General Counsel
No securities owned |
| 03 Sep 2026 |
Form 4: Ragusa Robert P, Director
Received 5,686 shares as a grant or award · Granted 25,599 Stock Option (Right to Buy) |
| 03 Sep 2026 |
Form 3: Ragusa Robert P, Director
No securities owned |
| 01 Sep 2026 |
8-K: Departure/Election of Directors or Officers; Compensation
On August 28, 2026, the board of directors (the “Board”) of Alamar Biosciences, Inc. (the “Company”) appointed Robert Ragusa to the Board, effective as of September 1, 2026. Mr. Ragusa will serve as a Class I Director, with an initial te... |
| 13 Aug 2026 | SCHEDULE 13G |
Loading...